New cancer vaccine shows early promise for patients with HER2-positive cancers
Sunday, September 30, 2018 - 17:10
in Health & Medicine
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according to data from a phase I clinical trial.